Market Cap 84.74M
Revenue (ttm) 0.00
Net Income (ttm) -147.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 115,100
Avg Vol 203,712
Day's Range N/A - N/A
Shares Out 50.14M
Stochastic %K 85%
Beta 0.86
Analysts Hold
Price Target $2.00

Latest News on HLVX

Frazier Life Sciences Appoints Aditya Kohli to Partner

Apr 17, 2025, 8:00 AM EDT - 2 days ago

Frazier Life Sciences Appoints Aditya Kohli to Partner

PHAT


Gold Falls Over 1%; HilleVax Shares Plunge

Jul 8, 2024, 2:31 PM EDT - 10 months ago

Gold Falls Over 1%; HilleVax Shares Plunge